Holen Sie sich die Stockscreener-App
0.0608
10.14%
0.0056
Windtree Therapeutics Inc Aktie (WINT) Neueste Nachrichten
Windtree Therapeutics to purchase Arizona company - Pennsylvania Business Report -
Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime - MSN
Scottsdale-based real estate fintech CommLoan to be acquired by Philadelphia-area firm - The Business Journals
Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference - MSN
Windtree Therapeutics to buy commercial real estate fintech in latest diversification attempt - The Business Journals
Windtree Therapeutics Issues Convertible Notes for Acquisition - The Globe and Mail
Windtree Therapeutics signs letter of intent to acquire CommLoan By Investing.com - Investing.com Nigeria
Windtree Therapeutics To Acquire CommLoan - citybiz
Windtree Therapeutics announces it has signed a letter of intent to acquire CommLoan - marketscreener.com
Windtree Therapeutics (WINT) to Acquire CommLoan: A Strategic Mo - GuruFocus
Windtree Therapeutics signs letter of intent to acquire CommLoan - Investing.com
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space - The Manila Times
Windtree Therapeutics (WINT) signs LOI to acquire fintech lender CommLoan - Stock Titan
WINT SEC FilingsWindtree Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal - Investing.com Nigeria
Windtree Therapeutics issues $857,143 in convertible notes linked to CommLoan deal By Investing.com - Investing.com South Africa
Windtree Therapeutics (WINT) raises $857K via 2026 convertible notes for CommLoan LOI - Stock Titan
Windtree Therapeutics, Inc. signed a letter of intent to acquire CommLoan, Inc. - marketscreener.com
Windtree Therapeutics Delays Quarterly Report Filing - MSN
Windtree Expands Global Patent Portfolio as Heart Failure Pipeline Gains Momentum - MSN
Windtree Signals Possible Windfall as Partner Revives Lifesaving Infant Lung Treatments - MSN
Warrington’s Windtree Therapeutics Calls Off Acquisition of Titan Environmental Services - BUCKSCO.Today
Windtree Secures $7.5M as Planned Environmental Services Deal Is Called Off - MSN
Windtree Therapeutics Approves Key Financial Structure Changes - MSN
Why Windtree Therapeutics Inc. stock could benefit from AI revolution2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Can Windtree Therapeutics Inc. stock hit analyst price targetsQuarterly Investment Review & Precise Buy Zone Identification - newser.com
Why Windtree Therapeutics Inc. stock is recommended by analystsNew Guidance & High Conviction Investment Ideas - newser.com
Will Windtree Therapeutics Inc. price bounce be sustainableMarket Risk Summary & Expert Verified Movement Alerts - newser.com
What’s next for Windtree Therapeutics Inc. stock priceTake Profit & Consistent Growth Equity Picks - newser.com
Is Windtree Therapeutics Inc. stock a good choice for value investorsJobs Report & Verified Momentum Stock Ideas - newser.com
Live market analysis of Windtree Therapeutics Inc.2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
Using portfolio simulators with Windtree Therapeutics Inc. includedEarnings Growth Summary & Entry Point Strategy Guides - newser.com
1.44%
0.91%
Kapitalisierung:
|
Volumen (24h):